Innovent Biologics, Inc. (IVBXF)
OTCMKTS
· Delayed Price · Currency is USD
5.98
+0.01 (0.08%)
Apr 23, 2025, 4:00 PM EDT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $10.93 billion as of April 24, 2025. Its market cap has increased by 37.04% in one year.
Market Cap
10.93B
Enterprise Value
10.24B
Revenue
1.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.98
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 10.93B, an increase of 362.27%. That is a compound annual growth rate of 26.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.69B |
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 704.15M |
| Northwest Biotherapeutics | 489.55M |
| Elite Pharmaceuticals | 449.74M |
| Glass House Brands | 419.36M |
| CytoDyn | 251.42M |